Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06605703 · ClinicalTrials.gov registry record · Phase 4

A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)

A Phase 4 study of Obesity and Overweight, sponsored by WW International.

Active
Registry status
Phase 4
Development phase
226
Enrollment target
1
Study location

NCT06605703: Active Phase 4 study of Obesity and Overweight, sponsored by WW International.

NCT06605703 is a Phase 4 study of Obesity and Overweight that is active but no longer recruiting, run by WW International. The registered enrollment target is 226 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06605703, a Phase 4 study of Obesity and Overweight, is active but no longer recruiting, sponsored by WW International.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
226 participants
Enrollment target
1
Study location

Study Summary

The study compares the effectiveness of treatment options for weight management after discontinuing semaglutide and tirzepatide. The primary outcome is absolute and percentage weight change at 12-weeks.

Conditions Studied

Obesity Overweight

Interventions

  • BEHAVIORAL WW Clinic
  • DRUG Bupropion-Naltrexone
  • DRUG Bupropion-Naltrexone-Metformin

Study Locations (1)

New York

  • WW International, Inc - New York

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2024-09-18
Est. Completion 2026-09
Phase Phase 4

Sponsor

WW International

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06605703

The ClinicalTrials.gov registry entry for NCT06605703 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (72% lower). The listed sponsor is WW International, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which WW Clinic is the first listed.

NCT06605703 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06605703 about?

NCT06605703 is a clinical study titled "A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)". The study compares the effectiveness of treatment options for weight management after discontinuing semaglutide and tirzepatide. The primary outcome is absolute and percentage weight change at 12-weeks.

What is the current status of trial NCT06605703?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 226 participants. The study started on 2024-09-18. Estimated completion is 2026-09.

What conditions does trial NCT06605703 study?

This clinical trial studies the following conditions: Obesity, Overweight.

What interventions are being tested in trial NCT06605703?

The interventions under investigation include: WW Clinic (BEHAVIORAL), Bupropion-Naltrexone (DRUG), Bupropion-Naltrexone-Metformin (DRUG).

Who is sponsoring clinical trial NCT06605703?

This trial is sponsored by WW International, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06605703 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Overweight

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.